205 related articles for article (PubMed ID: 38612489)
1. The Probiotic
Schwarcz R; Foo A; Sathyasaikumar KV; Notarangelo FM
Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612489
[TBL] [Abstract][Full Text] [Related]
2. Assessment of Prenatal Kynurenine Metabolism Using Tissue Slices: Focus on the Neosynthesis of Kynurenic Acid in Mice.
Notarangelo FM; Beggiato S; Schwarcz R
Dev Neurosci; 2019; 41(1-2):102-111. PubMed ID: 31117076
[TBL] [Abstract][Full Text] [Related]
3. Prenatal Dynamics of Kynurenine Pathway Metabolism in Mice: Focus on Kynurenic Acid.
Goeden N; Notarangelo FM; Pocivavsek A; Beggiato S; Bonnin A; Schwarcz R
Dev Neurosci; 2017; 39(6):519-528. PubMed ID: 29080891
[TBL] [Abstract][Full Text] [Related]
4. Role of d-amino acid oxidase in the production of kynurenine pathway metabolites from d-tryptophan in mice.
Notarangelo FM; Wang XD; Horning KJ; Schwarcz R
J Neurochem; 2016 Feb; 136(4):804-814. PubMed ID: 26661897
[TBL] [Abstract][Full Text] [Related]
5. On the relationship between the two branches of the kynurenine pathway in the rat brain in vivo.
Amori L; Guidetti P; Pellicciari R; Kajii Y; Schwarcz R
J Neurochem; 2009 Apr; 109(2):316-25. PubMed ID: 19226371
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of Large Neutral Amino Acid Transporters Suppresses Kynurenic Acid Production Via Inhibition of Kynurenine Uptake in Rodent Brain.
Sekine A; Kuroki Y; Urata T; Mori N; Fukuwatari T
Neurochem Res; 2016 Sep; 41(9):2256-66. PubMed ID: 27161376
[TBL] [Abstract][Full Text] [Related]
7. Probiotic Lactobacillus Plantarum 299v decreases kynurenine concentration and improves cognitive functions in patients with major depression: A double-blind, randomized, placebo controlled study.
Rudzki L; Ostrowska L; Pawlak D; Małus A; Pawlak K; Waszkiewicz N; Szulc A
Psychoneuroendocrinology; 2019 Feb; 100():213-222. PubMed ID: 30388595
[TBL] [Abstract][Full Text] [Related]
8. Kynurenic Acid Levels and Kynurenine Aminotransferase I, II and III Activities in Ganglia, Heart and Liver of Snail Helix Pomatia.
Kronsteiner C; Baran H; Kepplinger B
Cell Physiol Biochem; 2023 Aug; 57(4):279-297. PubMed ID: 37597169
[TBL] [Abstract][Full Text] [Related]
9. Galantamine-Memantine Combination and Kynurenine Pathway Enzyme Inhibitors in the Treatment of Neuropsychiatric Disorders.
Bai MY; Lovejoy DB; Guillemin GJ; Kozak R; Stone TW; Koola MM
Complex Psychiatry; 2021 Aug; 7(1-2):19-33. PubMed ID: 35141700
[TBL] [Abstract][Full Text] [Related]
10. The Synthesis of Kynurenic Acid in Mammals: An Updated Kynurenine Aminotransferase Structural KATalogue.
Rossi F; Miggiano R; Ferraris DM; Rizzi M
Front Mol Biosci; 2019; 6():7. PubMed ID: 30873412
[TBL] [Abstract][Full Text] [Related]
11. Kynurenic acid and 3-hydroxykynurenine production from D-kynurenine in mice.
Wang XD; Notarangelo FM; Wang JZ; Schwarcz R
Brain Res; 2012 May; 1455():1-9. PubMed ID: 22498176
[TBL] [Abstract][Full Text] [Related]
12. A High-performance Liquid Chromatography Measurement of Kynurenine and Kynurenic Acid: Relating Biochemistry to Cognition and Sleep in Rats.
Baratta AM; Viechweg SS; Mong JA; Pocivavsek A
J Vis Exp; 2018 Aug; (138):. PubMed ID: 30176006
[TBL] [Abstract][Full Text] [Related]
13. N-Acetylcysteine Inhibits Kynurenine Aminotransferase II.
Blanco-Ayala T; Sathyasaikumar KV; Uys JD; Pérez-de-la-Cruz V; Pidugu LS; Schwarcz R
Neuroscience; 2020 Sep; 444():160-169. PubMed ID: 32768617
[TBL] [Abstract][Full Text] [Related]
14. L-Tryptophan-kynurenine pathway enzymes are therapeutic target for neuropsychiatric diseases: Focus on cell type differences.
Fujigaki H; Yamamoto Y; Saito K
Neuropharmacology; 2017 Jan; 112(Pt B):264-274. PubMed ID: 26767951
[TBL] [Abstract][Full Text] [Related]
15. Amino acids inhibit kynurenic acid formation via suppression of kynurenine uptake or kynurenic acid synthesis in rat brain in vitro.
Sekine A; Okamoto M; Kanatani Y; Sano M; Shibata K; Fukuwatari T
Springerplus; 2015; 4():48. PubMed ID: 25674503
[TBL] [Abstract][Full Text] [Related]
16. Age dependency of inhibition of alpha7 nicotinic receptors and tonically active N-methyl-D-aspartate receptors by endogenously produced kynurenic acid in the brain.
Alkondon M; Pereira EF; Eisenberg HM; Kajii Y; Schwarcz R; Albuquerque EX
J Pharmacol Exp Ther; 2011 Jun; 337(3):572-82. PubMed ID: 21270133
[TBL] [Abstract][Full Text] [Related]
17. Tryptophan Challenge in Healthy Controls and People with Schizophrenia: Acute Effects on Plasma Levels of Kynurenine, Kynurenic Acid and 5-Hydroxyindoleacetic Acid.
Sathyasaikumar KV; Notarangelo FM; Kelly DL; Rowland LM; Hare SM; Chen S; Mo C; Buchanan RW; Schwarcz R
Pharmaceuticals (Basel); 2022 Aug; 15(8):. PubMed ID: 36015151
[TBL] [Abstract][Full Text] [Related]
18. Kynurenate production by cultured human astrocytes.
Kiss C; Ceresoli-Borroni G; Guidetti P; Zielke CL; Zielke HR; Schwarcz R
J Neural Transm (Vienna); 2003 Jan; 110(1):1-14. PubMed ID: 12541009
[TBL] [Abstract][Full Text] [Related]
19. Perinatal kynurenine 3-hydroxylase inhibition in rodents: pathophysiological implications.
Ceresoli-Borroni G; Guidetti P; Amori L; Pellicciari R; Schwarcz R
J Neurosci Res; 2007 Mar; 85(4):845-54. PubMed ID: 17279543
[TBL] [Abstract][Full Text] [Related]
20. A systemically-available kynurenine aminotransferase II (KAT II) inhibitor restores nicotine-evoked glutamatergic activity in the cortex of rats.
Koshy Cherian A; Gritton H; Johnson DE; Young D; Kozak R; Sarter M
Neuropharmacology; 2014 Jul; 82():41-8. PubMed ID: 24647121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]